CAR T-cell therapy for leukemia leads to remissions in clinical trial – EurekAlert (press release)
|
CAR T-cell therapy for leukemia leads to remissions in clinical trial
EurekAlert (press release) "It was not known whether CAR T-cells could be used to treat these high risk CLL patients," said lead author Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch. "Our study shows that CD19 CAR T-cells are a highly promising treatment for CLL … |
